1975Drug and Therapeutics BulletinRequires access

Naloxone (narcan)

Author information unavailable

Open publisher page 1 citations

Abstract

Naloxone (Narcan - Winthrop), the N-allyl derivative of oxymorphone, is a narcotic antagonist whose most important clinical property is reversal of narcotic-induced respiratory depression. Like nalorphine (Lethidrone - Wellcome) and levallorphan (Lorfan - Roche), it also antagonises the sedative, analgesic and miotic effects of narcotic analgesics.1 There is, however, an important difference. When not preceded by the administration of a narcotic or when given in excess, nalorphine and levallorphan themselves have narcotic effects; by contrast, naloxone has none.2 It is, for all practical purposes, a pure antagonist, whereas nalorphine and levallorphan are partial agonists, with agonist as well as antagonist effects.3

About this research paper

What this paper is about

Naloxone (Narcan - Winthrop), the N-allyl derivative of oxymorphone, is a narcotic antagonist whose most important clinical property is reversal of narcotic-induced respiratory depression. Like nalorphine (Lethidrone - Wellcome) and levallorphan (Lorfan - Roche), it also antagonises the sedative, analgesic and miotic effects of narcotic analgesics.1 There is, however, an important difference. When not preceded by the administration of a narcotic or when given in excess, nalorphine and levallorphan themselves have narcotic effects; by contrast, naloxone has none.2 It is, for all practical purposes, a pure antagonist, whereas nalorphine and levallorphan are partial agonists, with agonist as well as antagonist effects.3

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Naloxone (Narcan - Winthrop), the N-allyl derivative of oxymorphone, is a narcotic antagonist whose most important clinical property is reversal of narcotic-induced respiratory depression. Like nalorphine (Lethidrone - Wellcome) and levallorphan (Lorfan - Roche), it also antagonises the sedative, analgesic and miotic effects of narcotic analgesics.1 There is, however, an important difference. When not preceded by the administration of a narcotic or when given in excess, nalorphine and levallorphan themselves have narcotic effects; by contrast, naloxone has none.2 It is, for all practical purposes, a pure antagonist, whereas nalorphine and levallorphan are partial agonists, with agonist as well as antagonist effects.3

Key concepts: Nalorphine, (+)-Naloxone, Narcotic antagonist, Narcotic antagonists, Narcotic, Medicine, Anesthesia, Oxymorphone

Related papers

Back to paper searchBrowse research topicsOriginal source
Naloxone (narcan) — Research Paper | ScholarLens